Reyes Financial Architecture, Inc.
Source: SEC Form 13F · as of Mar 2026Reyes Financial Architecture, Inc. holds 15 biotech & pharma companies tracked by BioSniper, totaling $1.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$1.4M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 3,588 | $432K |
| AMGNAMGEN INC | 1,215 | $427K |
| JNJJOHNSON & JOHNSON | 605 | $148K |
| LLYELI LILLY & Co | 146 | $134K |
| MEDPMedpace Holdings Inc. | 148 | $71K |
| INCYIncyte Corp. | 746 | $70K |
| ABBVAbbVie Inc. | 214 | $47K |
| PMPhilip Morris International Inc | 206 | $34K |
| KRYSKrystal Biotech, Inc. | 100 | $26K |
| ABTABBOTT LABORATORIES | 150 | $15K |
| BAXBaxter International Inc. | 653 | $11K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 36 | $10K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8 | $4K |
| DOMHDominari Holdings Inc. | 633 | $2K |
| CLDICalidi Biotherapeutics Inc. | 100 | $24 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.